Silver Line CRM

NOVEMBER 11, 2020

Reading time: 7 minutes As we all look to 2021, what are the pharmaceutical industry trends to build into your life sciences marketing strategy? But today, the need to satisfy patients, providers, payers, regulatory agencies, and shareholders alike — while staying ahead of the competition — takes the right technologies at the right time. .

Marketing 52

Marketing Pharmaceutical Side effects Insurance 52

World of DTC Marketing

AUGUST 19, 2022

This is going to lead to a lot of health problems and associated costs. Data from the Kaiser Family Foundation (KFF) shows that between 2011 and 2021, the average premiums for family coverage rose from $15,073 to $22,221—an increase of 47.4%. 1ne: A new analysis predicts that by 2030, 48.9% will be severely obese. percent of U.S.

Healthcare 204

Healthcare Healthcare Insurance Competition 204

Pharmaceutical Technology

JUNE 2, 2023

AB Science has secured a Canadian patent for its lead compound masitinib to treat amyotrophic lateral sclerosis (ALS), a fatal motor neuron disorder. This helps to prevent generic competition for eight years after initial approval. AB Science said that masitinib is also eligible for regulatory data protection in the country.

Food and Drug Administration 52

Food and Drug Administration Food Competition Medicine 52

Pharmaceutical Technology

MAY 11, 2023

GlobalData’s Internet of Things (IoT) Market report helps keep abreast of the latest trends in internet of things, market opportunity forecast and the competitive landscape. Of the 50 leading companies in the pharma industry, U.S. Buy the report here.

Media 52

Media Pharma Competition Marketing 52

European Pharmaceutical Review

JANUARY 9, 2023

The global life sciences mergers and acquisitions (M&A) investment totalled $105 billion in the first 11 months of 2022, with total deal value well down on 2021. Global M&A activity in 2022. EY’s research observed an overall drop in 2022 M&A investment worldwide. M&A predictions for 2023.

Biopharma 98

Biopharma Specialization Leads Competition 98

Pharmaceutical Technology

JANUARY 30, 2023

These are forecast to generate $264 billion in sales between 2021 and 2028. Comirnaty, which was first approved in the UK by an Emergency Use Approval (EUA) from the Medicines and Healthcare products Regulatory Agency (MHRA) on December 2, 2020, is currently the leading prophylactic vaccine with 2021 sales of $41.5

Sales 52

Sales Leads Competition Medicine 52

pharmaphorum

NOVEMBER 10, 2022

However, turnover fell back to $148 million in 2021, mainly as a result of strong competition from AstraZeneca and Merck & Co’s class-leading Lynparza (olaparib) – which has a much broader product label – as well as GSK’s Zejula (niraparib). With finances tight, Clovis has deferred a $1.9

Sales 59

Sales Competition Leads Marketing 59

European Pharmaceutical Review

NOVEMBER 3, 2022

The US was found to be the leading country within the industry and has one of the highest growth scores in the survey’s history. Competitiveness. India has built on its 2021 gains with a huge 15 percent improvement. Key countries. Germany (in second place) and the UK achieved double-digit growth. Finished Dosage.

Pharma 103

Pharma Manufacturing Competition Pharmaceutical products 103

pharmaphorum

JULY 21, 2022

The appointment might raise some eyebrows given Roche’s need to drive pharma sales as it copes with the loss of patent protection on an earlier generation of antibody-based therapies – now being hit by biosimilar competition – but Schwan is confident Schinecker is the right man to lead the company forward.

Sales 113

Sales Pharma Competition Management 113

Clarify Health

SEPTEMBER 23, 2022

Our team connected with marketing and strategy leaders across dozens of leading healthcare organizations at SHSMD’s Annual Connections Conference. This is crucial for systems looking to stay competitive in today’s market, where high acuity cases are tending to leave hospital ORs and migrate to ASCs.

Patients 52

Patients Recruitment Competition Marketing 52

Sales Talent

JANUARY 20, 2022

However, before you jump directly to our sales hiring predictions for 2022, take the time to read the entire article to learn how the intense competition for talent is impacting sales professionals’ salaries and employers’ strategies for winning the talent war. 2021 Sales Hiring in Review. At the end of 2021, there were 4.3M

Sales 52

Sales B2B Sales Competition Insurance 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. She holds a degree in biochemistry from Oxford University.

Medicine 91

Medicine Healthcare Healthcare Pharma 91

Clarivate

JULY 31, 2023

Following the acquisition of Dialog Solutions as part of the ProQuest M&A in December 2021, Dialog Solutions products and services will be folded into the Clarivate portfolio of offerings for Life Sciences & Healthcare. Today, the Dialog Solutions brand has been integrated into Clarivate.

Healthcare 52

Healthcare Healthcare Safety Competition 52

European Pharmaceutical Review

AUGUST 23, 2022

ON 11 JANUARY 2022, Regulation (EU) 2021/2282 on health technology assessment (HTA) came into force. Article 15 proved that transparent and effective assessments of new technologies were crucial to ensure fair competition between stakeholders that operate in the EU. Official Journal of the European Union; 2021. References.

Consulting 98

Consulting Medical Healthcare Healthcare 98

pharmaphorum

AUGUST 5, 2022

Such inorganic growth is no longer viable, argues Pervaise Khan, Accenture’s UK Life Sciences Lead. Through our recent report, Scientific innovations for more sustainable growth , we analysed over 300 M&A deals made by the world’s top 30 biopharma companies between 2010–2021.

Biopharma 52

Biopharma Marketing Pharma Relationship management 52

Clarivate

JANUARY 14, 2022

Highly Cited Researchers 2021 are based at more than 1,300 institutions. The Highly Cited Researchers campaign is an opportunity to introduce Korea University’s research competitiveness to our audience.”. We think Highly Cited Researchers are the most influential researchers leading in their fields.

Competition 98

Competition Distribution Media Leads 98

pharmaphorum

NOVEMBER 15, 2022

Emergent reported nasal naloxone sales fell 34% in the third quarter to $88 million from $133 million in the same period of 2021, so, with genericisation of the market having an impact, the challenge is on for OPNT003 to show it has a superior profile.

Sales 52

Sales Marketing FDA Pharma 52

Clarify Health

APRIL 20, 2022

in 2021, while Original Medicare enrollment fell by 2.6%. Aetna, Centene, and UnitedHealth Group currently lead the market with the most year-over-year growth. In 2022, there was an 8% increase in the number of Medicare Advantage plans available to consumers, further heightening the high-growth, competitively surged market.

Networking 52

Networking Competition Marketing Consulting 52

pharmaphorum

DECEMBER 13, 2022

Amgen has its first direct competition in the KRAS inhibitor class following FDA approval of Mirati’s adagrasib as Krazati for a form of lung cancer. Analysts have suggested, however, that the profile of the two drugs is very similar, leading to questions about how successful Mirati will be differentiating Krazati from its rival.

FDA 52

FDA Side effects Competition Patients 52

Clarify Health

MARCH 26, 2024

However, new regulations from the Centers for Medicare & Medicaid Service in 2021 aim to change that. As hospitals become more familiar with the mechanics of price transparency, they can start to post more comprehensive data in addition to prices to further differentiate from the competition. over the previous year.

Healthcare 52

Healthcare Healthcare Patients Competition 52

Clarify Health

AUGUST 15, 2023

The Centers for Medicare and Medicaid Services (CMS) tried to tackle this problem through its price transparency rules, which went into effect for hospitals in 2021 and health plans in 2023. Dig deeper into strategies for hospital growth and differentiation in competitive markets in our 2023 Growth Playbook.

Insurance 52

Insurance Healthcare Healthcare Competition 52

Clarify Health

MARCH 2, 2022

In 2021, Mercer evaluated over 280 high-quality provider networks across 97 markets using Clarify Networks , a cloud analytics software that uses AI and machine learning to optimize network quality, efficiency, and referral patterns. It will help enable competitive coverage for Mercer’s clients so that employees have greater access to care.

Networking 52

Networking Competition Professional Services Marketing 52

Clarify Health

SEPTEMBER 23, 2022

Our team connected with marketing and strategy leaders across dozens of leading healthcare organizations at SHSMD’s Annual Connections Conference. This is crucial for systems looking to stay competitive in today’s market, where high acuity cases are tending to leave hospital ORs and migrate to ASCs.

Patients 40

Patients Recruitment Competition Marketing 40

Rep-Lite

JULY 27, 2023

Moreover, we’ll shed light on the evolution of medical sales techniques and strategies, the impact of technology, and the importance of talent acquisition to thrive in this competitive domain. Attracting and Retaining Top Sales Talent A competitive compensation package is just the beginning.

Sales 52

Sales Medical Medical sales Sales Strategy 52

Clarify Health

FEBRUARY 8, 2022

2021 launched a new era for healthcare price transparency. In January 2021, the Healthcare Price Transparency Act went into effect, requiring hospitals to publish their cash pay rates and rates negotiated with health insurance companies.

Networking 52

Networking Marketing Competition Healthcare 52

Pharmaceutical Representative Training

OCTOBER 9, 2024

In the competitive world of pharmaceutical sales, effectively handling customer objections is crucial for success. 3 By actively listening to providers and addressing their objections with tailored solutions, sales professionals can cultivate strong relationships that lead to success in this competitive field. link] Jacoby, D.

Sales 52

Sales Pharma Pharmaceutical Sales Prospecting 52

pharmaphorum

JANUARY 5, 2023

The drive to make the UK a ‘scientific powerhouse’ was central to the government’s announcement closing out 2022 , which appointed five industry experts to lead on the sectors most vital to UK’s future innovation. For biotech to achieve our societal goals, we need to build up the foundational systems that support modern science.

Manufacturing 93

Manufacturing Government Leads Electronics 93

Medico Reach

OCTOBER 17, 2022

billion in 2021, with a compounded annual growth rate (CAGR) of 3.1% However, this can lead to several issues, such as: Implantation resistance due to reactionary metabolism Allergic reactions to the nickel component found in stainless steel composites Widespread bone destruction due to immunological responses to cobalt particles.

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

LEVO Health

JULY 15, 2024

In 2021, the GLP-1 market was valued at $16.53 To stand out in this competitive landscape, businesses must focus on patient engagement, comprehensive service offerings, strong marketing and branding, and strategic partnerships with top-tier telehealth service providers like WellSync and medical marketing experts like Levo Health.

Marketing 52

Marketing Side effects Education Medical 52

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. What’s leading to the boom in development of semaglutide biosimilars? Per recent Clarivate estimates, the therapeutic market for these drugs is valued at approximately $1.7

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

Pharmaceutical Technology

MAY 16, 2023

Although Sanofi may face generic drug competition this year for its multiple sclerosis drug, Aubagio, the company is expected to maintain their sales of Dupixent, accounting for 43.3% of Sanofi’s annual consensus sales forecast growth from 2021 to 2028, according to GlobalData’s report, ‘Looking ahead to 2023 – the future of pharma’.

Marketing 52

Marketing Sales Pharma Leads 52

Pharmaceutical Technology

JUNE 29, 2022

In September 2021, GlobalData figures revealed there to be 1,320 industry-sponsored regenerative medicine and advanced therapy trials ongoing worldwide. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market.

Specialization 118

Specialization Biopharma B2B Sales Manufacturing 118

Pharmaceutical Technology

SEPTEMBER 22, 2022

The World Health Organization (WHO) reports that cardiovascular disease is the major leading cause of death, with 17.9 In 2021, the WHO and the United Nations announced a plan to reduce premature mortality related to noncommunicable diseases, including cardiovascular disease, by 25% leading up to 2025.

Pharmaceutical 52

Pharmaceutical Marketing FDA Leads 52

The Marketing Advantage

MARCH 9, 2021

March 9, 2021 Critical to optimizing sales force productivity and efficiency is identifying the right HCP and/or account targets. However, if all products in the market are chasing the largest segment of that market, then this segment consequentially becomes the most competitive.

Sales 52

Sales Competition Marketing Biopharma 52

Healthcare Success

MAY 19, 2022

As we mentioned earlier, nearly three in four doctors now work for a hospital, health system, or corporate entity, according to an April 2022 survey from Avalere Health —a 7% increase from 2021 and a nearly 20% jump from 2019. This step is particularly crucial in an era where new competition enters the market every day.

Marketing 52

Marketing Physicians Doctors Competition 52

Cesare Ferrari

FEBRUARY 9, 2023

Understanding where the company’s product is situated in the matrix below, published by Keith Goffin, Aleksei Beznosov, & Matthias Seiler in 2021 , could help define the possible moves. Without being unique and extremely innovative, the position is vulnerable if competition start eroding margins.

Marketing 52

Marketing Competition Medical Sales 52

Impetus Digital

AUGUST 2, 2024

Unsurprisingly, the US FDA has reported a noticeable increase in the number of submissions that use AI/machine learning (ML) components in recent years; in 2021, they received more than 100 submissions wherein AI use was reported. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.

Pharma 95

Pharma Manufacturing Medicine Marketing 95